Algo version: 0.98b
Sunder Biomedical Tech Co is listed at the TWO Exchange
Sunder Biomedical Tech Co [4115.TWO]
TWO Sector: Healthcare Industry:Medical Instruments Supplies

Is Sunder Biomedical Tech Co stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Sunder Biomedical Tech Co pays dividends. Last time was Thursday 1st of January 1970 where the investors holding the stock on Tuesday 25th of July 2023 were paid TWD0.3 per share. Over the last 1 times between 2023 and 2023, Sunder Biomedical Tech Co has paid TWD0.3 with an average of TWD0.3 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Sunder Biomedical Tech Co 10 years ago, but if you had invested on Thursday 1st of September 2022 when the price was TWD27.95, you would have made a loss of TWD-17.70 per share or -63.33%

No, the average daily trading liquidity for Sunder Biomedical Tech Co is TWD21 284 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Sunder Biomedical Tech Co has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.16, the company's ability to pay off the debt is normal. The company has a very low net profit margin of 2.21%, which is challenging.

We have calculated the inflation risk for Sunder Biomedical Tech Co to be low [0.5 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.